Advanced Rectal Cancer Current Events | Advanced Rectal Cancer News | 4
|
| Page
4 of
105 |
2089 Results |
|
|
|
Sort By:
Page Views | Date |
Chemotherapy after surgery extends survival for patients with advanced endometrial cancer
A new study has shown for the first time that giving two chemotherapy drugs to women with advanced endometrial cancer after surgery reduced the risk of recurrence by 29% and extended survival by 32% compared with women who received whole abdominal irradiation. view more (2005-12-06)
Stem cell protein offers a new cancer target
A protein abundant in embryonic stem cells is now shown to be important in cancer, and offers a possible new target for drug development, report researchers from the Stem Cell Program at Children's Hospital Boston. view more (2009-06-02)
Drug shows promise against advanced form of lung cancer
Results of a multi-center clinical study of a drug currently approved for treatment of kidney cancer indicate that it may also be effective for people with recurrent and advanced lung cancer. view more (2006-06-05)
Women with advanced ovarian cancer survive longer when treated with paclitaxel (Taxol) and cisplatin than with cyclophosphamide-cisplatin therapy
Embargoed for release: Tuesday 22 October, 09.30 (Europe), 08.30 (GMT) Women with advanced ovarian cancer survive longer when treated with Taxol (paclitaxel) and cisplatin than with cyclophosphamide-cisplatin... view more... (2002-10-19)
Cellular molecule spurs growth of prostate cancer
University of North Carolina at Chapel Hill scientists have identified a molecule that stimulates the aggressive growth of prostate cancer. view more (2005-11-29)
Palliative care intervention for patients with advanced cancer provides quality of life benefits
Patients with advanced cancer who received a palliative care intervention focused on addressing physical and psychosocial issues and care coordination that was provided at the same time as cancer treatment reported improved quality of life and mood but did not experience a significant change in the number of days in the hospital or the severity of... view more... (2009-08-19)
Should the UK lower the age for prostate cancer detection?
Prostate cancer screening occurs in many countries ahead of evidence from ongoing trials. In many countries, early detection (including the UK, when practised), and opportunistic screening commences at 50 years, but a lower age limit has recently been adopted in the USA based on two studies that found elevated prostate specific antigen (PSA)... view more... (2007-11-16)
Tumor response may not be best measure of efficacy in non-small cell lung cancer treatment
Researchers typically evaluate the effectiveness of a new cancer treatment by looking at how tumors respond to it. But in the case of advanced non-small cell lung cancer, there may be a better way to assess effectiveness. view more (2006-06-06)
'Casodex' (bicalutamide) 150mg a cost effective treatment for the management of locally advanced prostate cancer[1]
18th January 2005: New health economic data published in the European Journal of Hospital Pharmacy outline the cost benefits of the non-steroidal anti-androgen bicalutamide 150mg for the treatment of locally advanced prostate cancer. By delaying disease progression in patients with locally advanced prostate cancer, bicalutamide 150mg reduces the... view more... (2005-01-18)
Study examines factors associated with survival in advanced laryngeal cancer
Type of treatment, sex, race and insurance status are associated with survival rates among patients with advanced laryngeal cancer, according to a report in the December issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals. view more (2007-12-18)
Personalized diets may offer relief to advanced cancer patients
It is well known that cancer patients undergoing chemotherapy and radiation therapy often experience nausea and loss of appetite. But until now, few researchers have looked into why this happens and what can be done to ensure that cancer patients maintain a healthy diet during treatment. view more (2007-03-12)
Lung cancer survival rates may be linked to access to care
New research suggests that the lower survival rates of blacks with lung cancer may be explained by access to care. view more (2006-02-06)
Low-dose chemotherapy plus antiangiogenesis drug has activity in advanced breast cancer
Chemotherapy given in low, frequent doses - a novel strategy called "metronomic" delivery - achieved partial shrinkage of disease in some advanced breast cancer patients when given concurrently with an angiogenesis inhibitor. view more (2005-12-09)
Study shows drug combination improves outcome for advanced non-small cell lung cancer
A new, international study found that the combination of two drugs delays disease progression for patients with advanced non-small cell lung cancer (NSCLC). view more (2009-06-01)
Controversies Regarding Ovarian Cancer Treatments Addressed
Trials have raised questions on the current management and standard of care for advanced ovarian cancer (AOC). These controversies highlight implications for future clinical research and policy-making, as reviewed in an article published in the International Journal of Gynecological Cancer. view more (2004-11-10)
Skin rash in patients treated for liver cancer determines survival
In a study of a new chemotherapy drug for liver cancer, researchers found that the development of a skin rash correlated directly with the patient's response to treatment. view more (2006-06-05)
The effective chemoradiotherapy method for pancreatic cancer
Pancreatic cancer is the fifth most common cause of cancer death in Japan. The prognosis is extremely poor because it is difficult to detect this disease in the early stage and also the postoperative incidence of recurrence is still high, and we have not had any effective treatment for inoperable patients. view more (2008-09-22)
Experimental agent blocks prostate cancer in animal study
An experimental drug has blocked the progression of prostate cancer in an animal model with an aggressive form of the disease, new research shows. view more (2008-05-23)
Blacks with bladder cancer have more aggressive tumors, worse survival, U-M study finds
Black patients with bladder cancer are 35 percent more likely to die of the disease than white patients, according to a new study from the University of Michigan Comprehensive Cancer Center. view more (2006-09-22)
Online tool supports more dialogue on prostate cancer risk
A comprehensive, clinical nomogram tool, the Sunnybrook Prostate Cancer Risk Calculator - the first to use all known risk factors for prostate cancer - is available online to help men determine individual prostate cancer risk in consultation with their primary care physician. view more (2008-02-05)
|
|
| Page
4 of
105 |
2089 Results |
|
|
|
Sort By:
Page Views | Date |
|
